You searched for MSD/page/6/about:blank - European Biotechnology Magazine

Stay up to date every week with the european biotechnology newsletter.

Name

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Stay up to date every week with the european biotechnology newsletter.

Name

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

go to the article

go back to the homepage

Subscription
Newsletter
Advertise

Latest news
Background
Opinion
The Mag
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

New Search

If you are not happy with the results below please do another search

LATEST NEWS

Recordati secures ex-U.S. rights to Ionis’ Alexan...

ADC Therapeutics cuts 17% of staff after safety set...

Novartis signs up to $1.9bn deal to tap Antares’...

MAGAZINE

1 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

2 / 4

10/3/26 mw: Satz, PDF an JE, danach zu Andi

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

3 / 4

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

4 / 4

Investors are showing enormous interest in the topic of longevity, as well as in combating chronic diseases. This is because these diseases have a negative impact on life expectancy. The USA and China … more ➔

SPONSORED PUBLICATION

1 / 2

Indivumed

Indivumed, ready to set sail to the clinic

With the separation from the biobank service business, Hamburg-based Indivumed has repositioned itself as a therapeutics biotech. Its earlier work remains the core of its medical knowledge and the … more ➔

2 / 2

Mammalian cell culture

3PBIOVIAN expands its mammalian capacity with an additional 2,000 L bioreactor

3PBIOVIAN has added an additional 2,000-liter single-use bioreactor for mammalian cell culture, further strengthening its industrial capacity and reinforcing its value proposition as a CDMO partner … more ➔

Knowbio GmbH

Link to LinkedIn
Link to Instagram

Contact
Imprint
Privacy policy

Scroll to top